Paul W. Hoelscher, EVP, CFO at Horizon Therapeutics Public Ltd Co (HZNP), sold 205,850 shares at $90.01 ($18.5M) on 2021-05-14, disclosed to the SEC on 2021-05-14.
Open-market sale of $18.5M HZNP by EVP, CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.01 | 102,925 | $9.3M | 50.0% |
| 2 | $90.01 | 102,925 | $9.3M | 50.0% |
| Total | $90.01 avg | 205,850 | $18.5M | 100% |
| Filing → |
| HZNP | SELL | 2022-03-25 | $5.7M | — | Filing → |
| HZNP | SELL | 2021-12-30 | $943K | — | Filing → |
| HZNP | SELL | 2020-08-25 | $4.5M | — | Filing → |